Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc D Breton

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Diabetes Technology & Therapeutics|June 15, 2017
Handling Exercise During Closed Loop ControlMarc D Breton
Journal of Diabetes Science and Technology|November 4, 2009
Physical activity-the major unaccounted impediment to closed loop controlMarc D Breton
Journal of Diabetes Science and Technology|July 24, 2018
Diabetes Technological Revolution: Winners and Losers?Katharine D Barnard, Marc D Breton
Journal of Diabetes Science and Technology|June 2, 2010
Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico studyMarc D Breton, Boris P Kovatchev
Diabetes Technology & Therapeutics|March 30, 2021
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop TechnologyMarc D Breton, Boris P Kovatchev
Journal of Diabetes Science and Technology|November 11, 2015
Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 DiabetesBoris P Kovatchev, Marc D Breton
Journal of Diabetes Science and Technology|June 1, 2017
Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico StudyEnrique Campos-Náñez, Marc D Breton
Diabetes Technology & Therapeutics|September 26, 2023
Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical CareLaurel H Messer, Marc D Breton
Diabetes Technology & Therapeutics|April 24, 2020
Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network ModelsTaisa Kushner, Marc D Breton, Sriram Sankaranarayanan
Sensors (Basel, Switzerland)|December 11, 2019
Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia ContributionChiara Fabris, Basak Ozaslan, Marc D Breton
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Diabetes Technology & Therapeutics|June 15, 2017
Handling Exercise During Closed Loop ControlMarc D Breton
Journal of Diabetes Science and Technology|November 4, 2009
Physical activity-the major unaccounted impediment to closed loop controlMarc D Breton
Journal of Diabetes Science and Technology|July 24, 2018
Diabetes Technological Revolution: Winners and Losers?Katharine D Barnard, Marc D Breton
Journal of Diabetes Science and Technology|June 2, 2010
Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico studyMarc D Breton, Boris P Kovatchev
Diabetes Technology & Therapeutics|March 30, 2021
One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop TechnologyMarc D Breton, Boris P Kovatchev
Journal of Diabetes Science and Technology|November 11, 2015
Hemoglobin A1c and Self-Monitored Average Glucose: Validation of the Dynamical Tracking eA1c Algorithm in Type 1 DiabetesBoris P Kovatchev, Marc D Breton
Journal of Diabetes Science and Technology|June 1, 2017
Effect of BGM Accuracy on the Clinical Performance of CGM: An In-Silico StudyEnrique Campos-Náñez, Marc D Breton
Diabetes Technology & Therapeutics|September 26, 2023
Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical CareLaurel H Messer, Marc D Breton
Diabetes Technology & Therapeutics|April 24, 2020
Multi-Hour Blood Glucose Prediction in Type 1 Diabetes: A Patient-Specific Approach Using Shallow Neural Network ModelsTaisa Kushner, Marc D Breton, Sriram Sankaranarayanan
Sensors (Basel, Switzerland)|December 11, 2019
Continuous Glucose Monitors and Activity Trackers to Inform Insulin Dosing in Type 1 Diabetes: The University of Virginia ContributionChiara Fabris, Basak Ozaslan, Marc D Breton
Pageof 14